Klein Michael Frederick 4
4 · TRAVELERS COMPANIES, INC. · Filed Jul 23, 2026
Research Summary
AI-generated summary of this filing
Travelers (TRV) EVP Michael Klein Exercises Options and Sells Shares
What Happened
Michael F. Klein, Executive Vice President & President, Personal Insurance at Travelers (TRV), exercised 6,000 options on July 21, 2026 at $139.83 per share (cost ~$838,980) and, on the same day, sold a total of 6,000 TRV shares in two open-market transactions for approximately $2,196,562 in aggregate proceeds. The sales break down as 125 shares at a weighted average price of $364.90 (≈ $45,613) and 5,875 shares at a weighted average price of $366.12 (≈ $2,150,949). The filing also reports a derivative disposition of 6,000 shares at $0.00, which commonly reflects net settlement or withholding related to the exercise.
Key Details
- Transaction date: July 21, 2026; Form 4 filed July 23, 2026.
- Exercise: 6,000 shares at $139.83 — total cost $838,980.
- Sales: 125 shares @ $364.90 (weighted avg; see F1) and 5,875 shares @ $366.12 (weighted avg; see F2); total proceeds ≈ $2,196,562.
- Footnotes: F1/F2 note the weighted-average price ranges for the reported sales and offer to provide per-price sale counts on request.
- Shares owned after transaction: Not specified in the provided excerpt; however, the transactions (6,000 exercised and 6,000 sold) appear to result in no net increase in shares beneficially owned.
- Filing timeliness: Form 4 is dated July 23, 2026, two days after the July 21 transactions (appears to be a timely filing).
Context
This sequence—exercising options and selling roughly the same number of shares the same day—is often a cashless exercise or immediate monetization of vested options. The reported $0.00 derivative disposition typically indicates net share settlement or shares used to satisfy tax/withholding obligations tied to the exercise. Sales by executives can be routine liquidity events; they are not, by themselves, a clear signal of company outlook.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-07-21$139.83/sh+6,000$838,980→ 51,124.787 total - Sale
Common Stock
[F1]2026-07-21$364.90/sh−125$45,613→ 50,999.787 total - Sale
Common Stock
[F2]2026-07-21$366.12/sh−5,875$2,150,949→ 45,124.787 total - Exercise/Conversion
Stock Options (Right to Buy)
2026-07-21−6,000→ 30,037 totalExercise: $139.83From: 2024-02-02Exp: 2031-02-02→ Common Stock (6,000 underlying)
- 1,895.088(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents the weighted average sales price for price increments ranging from $364.72 to $365.03. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Represents the weighted average sales price for price increments ranging from $365.798 to $366.275. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.